2008
DOI: 10.1002/art.24316
|View full text |Cite
|
Sign up to set email alerts
|

C‐reactive protein and systemic lupus erythematosus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
84
0
2

Year Published

2009
2009
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 106 publications
(98 citation statements)
references
References 93 publications
6
84
0
2
Order By: Relevance
“…[2][3][4] Although autoantibodies, complement proteins, blood cell counts and erythrocyte sedimentation rate (ESR) can be helpful markers of diagnosis, prognosis, and/or degree of ongoing inflammation, distinction of disease activity from irreversible organ damage remains a challenge. 5 C-reactive protein (CRP) is usually a reliable marker of systemic inflammation, but this is not the case in SLE 6,7 or viral infections 8 probably due to interferon alpha (IFN dependent inhibition of hepatic CRP production. 9 Other biomarkers may reflect specific organ involvements, most notably lupus nephritis which is often mirrored by raised levels of autoantibodies against double-stranded (ds) DNA, nucleosomes and/or complement protein (C) 1q.…”
Section: Introductionmentioning
confidence: 99%
“…[2][3][4] Although autoantibodies, complement proteins, blood cell counts and erythrocyte sedimentation rate (ESR) can be helpful markers of diagnosis, prognosis, and/or degree of ongoing inflammation, distinction of disease activity from irreversible organ damage remains a challenge. 5 C-reactive protein (CRP) is usually a reliable marker of systemic inflammation, but this is not the case in SLE 6,7 or viral infections 8 probably due to interferon alpha (IFN dependent inhibition of hepatic CRP production. 9 Other biomarkers may reflect specific organ involvements, most notably lupus nephritis which is often mirrored by raised levels of autoantibodies against double-stranded (ds) DNA, nucleosomes and/or complement protein (C) 1q.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, although serum levels of CRP usually go in parallel with the disease activity in inflammatory states, the results from this point in SLE are inconclusive, being suggested that this autoimmune disease could be an exception (50). In this regard, while some authors have reported moderate levels of CRP (2.1 mg/l) in lupus subjects (51), others have associated this pathology with a high increase (15-16 mg/l) in this acute-phase protein (12).…”
Section: Discusionmentioning
confidence: 99%
“…Ukrywanie antygenów przed układem immunologicznym i przyspieszenie ich usuwania przez pentraksyny zapobiega autoimmunizacji. Uważa się, że niedobór CRP, SAP i PTX3 w toczniu rumieniowatym układowym odgrywa rolę w rozwoju i progresji choroby [53,54]. W związku z tym, że PTX3 jest syntetyzowana lokalnie w miejscu uszkodzenia i stanu zapalnego, szczególnie w obrębie naczyń, pojawiają się doniesienia o możliwości jej wykorzystania jako markera ich uszkodzenia [55].…”
Section: Pentraksynaunclassified